Robert Sexton
Corporate Officer/Principal at MUSTANG BIO, INC.
Network origin in Robert Sexton first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 21 | |
Public Company | Pharmaceuticals: Major | 18 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Robert Sexton via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Administrative Officer Corporate Officer/Principal | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
BIOGEN INC. | Pharmaceuticals: Major | Director/Board Member | |
TG THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Chief Executive Officer Director/Board Member | |
Rochester Christian University | College/University | Undergraduate Degree | |
NATIONAL HOLDINGS CORPORATION | Investment Banks/Brokers | Chairman Director/Board Member | |
KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Founder Chief Executive Officer | |
BRAINSTORM CELL THERAPEUTICS INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
FORTRESS BIOTECH, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Venatorx Pharmaceuticals, Inc.
Venatorx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Venatorx Pharmaceuticals, Inc. develops novel anti-infective agents to address the threat of antibiotic resistance. It offers antibiotic resistant bacteria and Carbapenem-resistant Enterobacteriaceae a family of gram-negative bacteria that are resistant to all known ?-lactam antibiotics, including penicillins, cephalosporins, monobactams, and carbapenems. The company was founded by Christopher J. Burns, Luigi Xerri, and Daniel Pevear in 2010 and is headquartered in Malvern, PA. | Miscellaneous Commercial Services | Chairman | |
Johnson & Johnson Innovation - JJDC, Inc.
Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Investment Managers | President | |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Corporate Officer/Principal Doctorate Degree | |
C. & J. Clark International Ltd.
C. & J. Clark International Ltd. Apparel/FootwearConsumer Non-Durables C. & J. Clark International Ltd. manufactures and retails footwear. Its brands include Clarks and Bostonian. It offers school, womens, mens, kids, and babies shoes and boots. The company was founded by Cyrus Clark and James Clark in 1825 and is headquartered in Somerset, the United Kingdom. | Apparel/Footwear | Director of Finance/CFO | |
The Pennsylvania State University | College/University | Undergraduate Degree Undergraduate Degree | |
University of Maryland | College/University | Doctorate Degree Graduate Degree | |
Yeshiva University | College/University | Undergraduate Degree Undergraduate Degree | |
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Hospital/Nursing Management | Corporate Officer/Principal | |
Nanjing University | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
PricewaterhouseCoopers LLP (Hong Kong)
PricewaterhouseCoopers LLP (Hong Kong) Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers LLP is a company based in Hong Kong, Hong Kong. The Chinese company specializes in providing services to help businesses achieve their tax objectives and strategically move forward. The company's focus is on building trust in society and solving important problems, and they work closely with clients to ensure they are ready to take advantage of new opportunities for growth. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The Hong Kong University of Science & Technology | College/University | Masters Business Admin | |
Hong Kong Institute of Certified Public Accountants
Hong Kong Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Hong Kong Institute of Certified Public Accountants operates under the professional accountant’s ordinance and works in the public interest. It offers CPA qualification programme and promulgating financial reporting, auditing and ethical standards in Hong Kong. The company was founded on January 1, 1973 and is headquartered in Hong Kong. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Opus Point Partners Management LLC
Opus Point Partners Management LLC Investment ManagersFinance Opus Point Partners Management LLC (OPPM) is a hedge fund manager headquartered in New York City. The firm was founded by Lindsay Rosenwald and Michael Weiss in 2009. They are owned by Opus Point Partners LLC, which is a subsidiary of Weiss & Co. LLC. OPPM manages investments that are dedicated to healthcare and life science. | Investment Managers | Chief Executive Officer Founder | |
Weill Cornell Medical College | College/University | Corporate Officer/Principal | |
Nanjingjinsirui Science & Technology Biology Corp.
Nanjingjinsirui Science & Technology Biology Corp. BiotechnologyHealth Technology Nanjing Genscript Co., Ltd. provides biological and pharmaceutical research services. It offers gene, peptide, protein production and purification, and antibody outsourcing services. The company was founded in 2004 and is headquartered in Nanjing, China. | Biotechnology | Sales & Marketing Chief Executive Officer | |
Albert Einstein College of Medicine, Inc. | College/University | Doctorate Degree | |
LAV Management Co., Ltd.
LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Investment Managers | Corporate Officer/Principal | |
Ernst & Young (China) | Corporate Officer/Principal | ||
Columbia Law School | College/University | Graduate Degree Graduate Degree | |
Arthur Andersen & Co. (Hong Kong)
Arthur Andersen & Co. (Hong Kong) Miscellaneous Commercial ServicesCommercial Services Arthur Andersen & Co. (Hong Kong) provides accounting services. The private company is based in Hong Kong, Hong Kong. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
American Brachytherapy Society | President | ||
Clinquest, Inc.
Clinquest, Inc. Pharmaceuticals: MajorHealth Technology Clinquest, Inc. provides healthcare product development services. It specializes in vigilance services for medical devices, investigational, and marketed products, medical information and complaint reporting, drug or device development consulting, clinical trial implementation, and data management and biostatistics. The company was founded July 30, 2002 and is headquartered in Hudson, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
ORIGO ACQUISITION CORP | Financial Conglomerates | Chief Executive Officer Chairman Director/Board Member Director/Board Member | |
Lundquist College of Business | College/University | Undergraduate Degree | |
GENSCRIPT BIOTECH CORPORATION | Biotechnology | Director/Board Member Director/Board Member Human Resources Officer | |
CHECKPOINT THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Investor Relations Contact | |
AVENUE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Investor Relations Contact | |
XILIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Helocyte, Inc.
Helocyte, Inc. Miscellaneous Commercial ServicesCommercial Services Helocyte, Inc. engages in the development and commercialization of immunotherapies for the prevention and treatment of cytomegalovirus or CMV (cancer and infectious disease). It focuses on developing PepVax, a HLA-restricted single antigen peptide vaccine for controlling CMV in allogeneic hematopoietic stem cell transplant recipients and Triplex. The company was founded by Donald J. Diamond in 2015 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Cyprium Therapeutics, Inc.
Cyprium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Fortress Biotech, Inc., Cyprium Therapeutics, Inc. is an American New York-based company focused on developing novel therapies for the treatment of Menkes disease and related copper metabolism disorders. The company was granted FDA breakthrough therapy, fast track, and rare pediatric disease designations, as well as FDA orphan drug designation for both Cutx-101 and AAV-ATP7A. The European Medicines Agency also granted orphan drug designation to Cyprium. In March 2017, Cyprium entered into a cooperative research and development agreement with the Eunice Kennedy Shriver National Institute of Child Health and Human Development to advance the clinical development of Cutx-101 for the treatment of Menkes disease. In 2023, Cyprium completed the transfer of its proprietary rights and assigned its FDA documents pertaining to Cutx-101 to Sentynl Therapeutics, Inc. Cyprium and NICHD also previously entered into a worldwide, exclusive license agreement to develop and commercialize AAV-ATP7A gene therapy, which is currently in pre-clinical development. The company was founded in 2017 by Michael Sean Weiss, Lindsay Allan Rosenwald, and Lung S. Yam, who has been the CEO since then. | Miscellaneous Commercial Services | Founder Founder | |
Cellvation, Inc. | Chairman Director/Board Member | ||
Protiviti Shanghai Co. Ltd.
Protiviti Shanghai Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Robert Half, Inc., Protiviti Shanghai Co. Ltd. is a business consulting firm based in Shanghai, China. The Chinese company provides IT consulting, Risk & Compliance, Digital Transformation, Internal Audit services. Additionally, Protiviti offers quantum computing services to help companies identify use cases, prepare for encryption risk, and harness the power of future quantum capabilities. The company's transaction services experts help clients gain a competitive advantage through well-executed transactions. Protiviti also offers Artificial Intelligence services to unlock business insights and increase competitive advantage through evidence-based analytics. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
JOURNEY MEDICAL CORPORATION | Pharmaceuticals: Major | Chairman Director/Board Member Investor Relations Contact | |
Baergic Bio, Inc.
Baergic Bio, Inc. Pharmaceuticals: MajorHealth Technology Baergic Bio, Inc. develops therapeutic drugs for the treatment of central nervous system disorders. It offers oncology, rare diseases, and gene therapy. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
AKERO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Caelum Biosciences, Inc.
Caelum Biosciences, Inc. BiotechnologyHealth Technology Caelum Biosciences, Inc. operates as a clinical-stage biotechnology company developing treatments for rare and life-threatening diseases. The company was founded in January 2017 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
AMTD IDEA GROUP | Investment Banks/Brokers | Director of Finance/CFO | |
CHINA GENERAL EDUCATION GROUP LIMITED | Other Consumer Services | Director/Board Member | |
Elpiscience Biopharma Ltd.
Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Pharmaceuticals: Major | Chief Executive Officer | |
Boston University School of Medicine | College/University | Doctorate Degree |
Statistics
International
United States | 37 |
China | 8 |
Hong Kong | 5 |
United Kingdom | 2 |
France | 2 |
Sectoral
Health Technology | 20 |
Consumer Services | 14 |
Commercial Services | 8 |
Finance | 7 |
Consumer Non-Durables | 2 |
Operational
Director/Board Member | 98 |
Corporate Officer/Principal | 65 |
Chairman | 31 |
Independent Dir/Board Member | 31 |
Chief Executive Officer | 27 |
Most connected contacts
Insiders | |
---|---|
Michael Weiss | 25 |
Fang Liang Zhang | 24 |
Lindsay Rosenwald | 23 |
Neil Herskowitz | 22 |
Tomas Jan Heyman | 18 |
Eliot Lurier | 13 |
Wai Man Yau | 12 |
Corazon Sanders | 12 |
Li Zhu | 12 |
Ying Huang | 11 |
Adam Chill | 11 |
Syed Rizvi | 9 |
Yuan Xu | 9 |
Patrick J. Casey | 9 |
Xiao Hui Ji | 9 |
- Stock Market
- Insiders
- Robert Sexton
- Company connections